New Key Statistics Module, Z-Score and F-Score
DHA:PHARMAID Key Ratios
Market Cap BDT M | 1,851.10 |
Enterprise Value BDT M | 1,838.62 |
P/E(ttm) | 27.51 |
PE Ratio without NRI | 27.67 |
Forward PE Ratio | -- |
Price/Book | 5.14 |
Price/Sales | 4.29 |
Price/Free Cash Flow | 156.88 |
Price/Owner Earnings | 108.76 |
Payout Ratio % | 0.05 |
Revenue (TTM) BDT M | 431.00 |
EPS (TTM) BDT | 21.57 |
Beneish M-Score | 0 |
10-y EBITDA Growth Rate % | 5.00 |
5-y EBITDA Growth Rate % | -7.50 |
y-y EBITDA Growth Rate % | 299.60 |
EV-to-EBIT | 19.94 |
EV-to-EBITDA | 18.58 |
PEG | -- |
Shares Outstanding M | 3.12 |
Net Margin (%) | 15.62 |
Operating Margin % | 21.09 |
Pre-tax Margin (%) | 21.31 |
Quick Ratio | 2.47 |
Current Ratio | 3.01 |
ROA % (ttm) | 14.65 |
ROE % (ttm) | 20.35 |
ROIC % (ttm) | 19.08 |
Dividend Yield % | 0.17 |
Altman Z-Score | 10.53 |
DHA:PHARMAID Number of Guru Trades
DHA:PHARMAID Volume of Guru Trades
Gurus Latest Trades with DHA:PHARMAID
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
DHA:PHARMAID is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data